6 ms·
Journey Colab – Psychedelic Drug Development from Sam Altman's Apollo Projects
- jeeshan 6y agoStarting with mescaline, we are developing a portfolio of plant-identical psychedelic compounds for FDA approval through a stakeholder model that includes the community of clinicians, non-profits, and Indigenous groups whose work is foundational to the success of this sector.
- reso 6y agoGreat direction to work in. Can't wait to see where Jee & co take this!
- jeeshan 6y agoCheers mate. Excited about HOW and WHO is building this as much as the WHAT.